low-density lipoprotein high-density lipoprotein particle subclasses predict coronary events favorably changed gemfibrozil therapy pubmed ncbi abstract background conventional lipid risk factors gemfibrozil treatment partially explain reductions coronary heart disease chd events experienced men veterans affairs high-density lipoprotein intervention trial va-hit examined measurement low-density lipoprotein ldl high-density lipoprotein hdl particle subclasses additional information relative chd risk reduction methods results prospective nested case-control study num men chd event nonfatal myocardial infarction cardiac death num year median follow-up num age-matched controls nuclear magnetic resonance nmr spectroscopy quantify levels ldl hdl particle subclasses particle sizes plasma obtained baseline num months treatment gemfibrozil placebo odds ratios num sd increment lipoprotein variable calculated adjusted logistic regression models gemfibrozil treatment increased ldl size lowered numbers ldl particles num raising numbers hdl particles num small hdl subclass particles num concentrations ldl hdl particles achieved gemfibrozil significant independent predictors chd events total ldl hdl particles odds ratios predicting chd benefit num num ci num num num num ci num num ldl hdl particle sizes chd events conclusions effects gemfibrozil nmr-measured ldl hdl particle subclasses reflected conventional lipoprotein cholesterol measures explain demonstrated benefit therapy patients low hdl cholesterol 
